![](/img/cover-not-exists.png)
A safety evaluation of canagliflozin: a first-in-class treatment for type 2 diabetes
Boyle, Luke D, Wilding, John PHVolume:
13
Language:
english
Journal:
Expert Opinion on Drug Safety
DOI:
10.1517/14740338.2014.959488
Date:
November, 2014
File:
PDF, 434 KB
english, 2014